EpigenCare uses epigenetics, blockchain and artificial intelligence innovation


EpigenCare, a personalised skin care technology startup, announced on 4th April that it had won the Johnson & Johnson Innovation competition for cutting-edge skin care technologies. Johnson & Johnson, the multinational consumer packaged goods manufacturing company, launched its innovation arm to identify progressive and forward-thinking digital beauty solutions. With a particular focus on personalisation items, it was set up to help consumers make better-informed decisions when it comes to their skin care routines. These leading trends in science and technology come at time, as Lee stated, when consumers are unaware of the true efficacy of skin care products, and when static genetic variants in current personal genomic tests cannot be modified by product ingredients. Focusing on epigenetics, blockchain and AI, Lee discussed an epigenetics-related solution that works by identifying a gene function's level of activity or inactivity.